Medical Newswire

Medical Newswire!

Medicine, Healthcare, Medical Research, Hospitals, Management
Press release distribution service
Home | Medical-Newswire.Com:

Bond & Taylor Warns Consumers that Study Links Actos® to Bladder Cancer

(Medical-NewsWire.com, November 01, 2012 ) Orange County, CA -- The law firm of Bond & Taylor is warning consumers of a study linking popular type 2 diabetes medication, Actos®, to bladder cancer. This newest study, published in the Journal of the National Cancer Institute was contributed by researchers at the Perelman School of Medicine at the University of Pennsylvania. Researchers found that patients taking thiazolidinedione (TZD) drugs such as Actos® (Pioglitazone) were two to three times more likely to develop bladder cancer than patients who took sulfonylurea drugs. This is especially disturbing news because TZD’s are prescribed to an estimated 20% of diabetes patients today.



This study reinforces government regulators’ opinions. In June 2011, the U.S. Food and Drug Administration released a warning to consumers that Actos® was under review for safety concerns. The FDA stated that based on a ten year meta study of Actos® patients, consumers who took Actos® for a year or longer were as much as 40% more likely to suffer from bladder cancer. According to the FDA, an estimated 2.35 million Americans filled a prescription for Actos® last year alone, and over 15 million prescriptions are written for this type 2 diabetes drug worldwide. This widespread usage could potentially have major effects upon bladder cancer statistics.



According to the National Cancer Institute, there are an estimated 70,530 cases of bladder cancer in the U.S. each year and 14,680 deaths. These numbers could rise significantly based upon Actos® performance in recent studies. Bond & Taylor is encouraging patients taking Actos® to review potential side effects with their doctor. Should a patient develop bladder cancer, the law firm of Bond & Taylor would like to offer a free consultation to discuss eligibility for compensation.



About Bond & Taylor



Extensive product liability experience gives Andrew L. Wright the expertise necessary to handle your defective prescription drug case. With over 20 years of experience as a trial lawyer, Andrew L. Wright is used to staring down the prescription drug makers and achieving results for his clients.



The law firm of Bond & Taylor has over 30 years of experience fighting zealously on behalf of injured clients and grieving families who have lost loved ones due to negligence. Bond & Taylor’s product liability attorneys are experts at fighting to achieve the justice clients deserve. The attorneys at Bond & Taylor are passionate advocates who treat clients with compassion and respect. Our firm wants to help clients obtain the compensation that they need to find relief. Cases are accepted nationwide; call today for a free consultation. (800) 471-0314 http://www.bondtaylorlaw.com

Bond & Taylor

Catherine Hess

949 988-7100 x 722

chess@webshark360.com

Source: EmailWire.Com

Source: EmailWire.com


Medical Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Healthcare resource center today to browse our selection of 600+ complimentary Healthcare magazines, white papers, webinars, podcasts, and more. Get popular titles including:

Eyecare Business
Medical Laboratory Observer
FierceHealthcare

No credit cards, coupons, or promo codes required. Try it today!

Medical Sponsors

Health News


Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com. CityRegions.Com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © 2012 GroupWeb Media LLC. All Rights Reserved.


GroupWeb Media Network
AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | iCameroon.com | i-Canada-News.Com | i-SoftwareNews.com | iT-NewsWire.Com
| InvestorsNewsDesk.Com | i-TravelNewsWire.Com | LegalLaw247.com | Medical-NewsWire.com | MiningNewsWire.net | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | Shopping-NewsWire.com | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com |
Medical-Newswire.com - Medicl Newswire and Press Release service of GroupWeb Media LLC